ADVFN US – Market Content Editor
-

Draganfly Shares Climb After Securing Second Order from Fortune 50 Telecom Giant
Draganfly Inc. (NASDAQ:DPRO) gained 6% in Thursday’s premarket session following news that the drone technology firm has received a second purchase order from a major Fortune 50 telecommunications provider. The latest order includes several units of Draganfly’s Commander 3XL drone platform equipped with Unmanned Systems & Solutions Inc.’s LEAP® tethered-power system. The customer is expanding…
-

Nuvve Shares Explode Higher After Japan Unit Wins Major Storage Battery Aggregation Contract
Nuvve Holding Corp. (NASDAQ:NVVE) surged more than 180% in premarket trading Thursday after revealing that its Japanese subsidiary has secured a significant aggregation deal involving stationary storage batteries in Japan. The agreement covers a large high-voltage storage system located in Tainai City, Niigata Prefecture, featuring 1,999 kW of output and 8,170 MWh of capacity. The…
-

Shoe Carnival Shares Gain After Company Moves to Rebrand as Shoe Station Group
Shoe Carnival Inc. (NASDAQ:SCVL) saw its shares rise 3.5% on Thursday after unveiling plans for a major corporate rebrand. The footwear retailer said it intends to change its name to Shoe Station Group, Inc., pending shareholder approval at its June 2026 annual meeting. The board unanimously backed the name change as part of a long-term…
-

TNL Mediagene Shares Rocket After Announcing Strategic Tie-Up With Coupang
TNL Mediagene (NASDAQ:TNMG) shares more than doubled in premarket trading Thursday after the Tokyo-based digital media and data firm unveiled a new strategic partnership with U.S. e-commerce giant Coupang aimed at strengthening its Content Commerce and Retail Media Network presence in Taiwan. The collaboration will tap into TNL Mediagene’s broad portfolio of premium editorial brands…
-

Brainsway Shares Jump After FDA Extends Deep TMS Approval to Teen Depression
Brainsway Ltd. (NASDAQ:BWAY) saw its stock pop 5% in premarket trading Thursday after securing a key FDA label expansion for its Deep Transcranial Magnetic Stimulation (Deep TMS) system, clearing the treatment for use in adolescents diagnosed with major depressive disorder (MDD). The updated approval authorizes Deep TMS as an add-on therapy for patients ages 15…
-

Six Flags Shares Climb as JANA Partners Reaffirms 9% Stake Despite Leadership Change
Six Flags Entertainment Corporation (NYSE:FUN) saw its stock rise 3.4% in premarket trading on Thursday after activist investor JANA Partners said it still holds roughly a 9% economic interest in the amusement park operator, even after a key member exited the group. JANA disclosed that Dave Habiger has stepped away from the coalition to “pursue…
-

TKO Group Shares Edge Higher on New Polymarket Partnership Covering UFC and Zuffa Boxing
TKO Group Holdings (NYSE:TKO) saw its shares gain about 2.3% in premarket trading after unveiling a multi-year agreement with Polymarket, which will serve as the Official and Exclusive Prediction Market Partner for both UFC and Zuffa Boxing. The deal marks the first time major fight organizations will incorporate prediction market technology into their products. As…
-

BioNTech Rejects Talk of Pfizer Stake Sale, Says Partnership Is Intact
BioNTech (NASDAQ:BNTX) pushed back on speculation Thursday that Pfizer (NYSE:PFE) may be preparing to unload its stake in the company, emphasizing that the two firms’ long-running alliance remains solid. A spokesperson for the German biotech firm said, “We continue to have a close and strong collaboration,” adding that BioNTech would not comment on any equity-related…
-

NextPlat Revenue Declines in Q3, but Shares Rise as Cost Cuts Start to Show Progress
NextPlat Corp (NASDAQ:NXPL) reported a decline in third-quarter revenue on Thursday, posting $13.8 million, down from $15.4 million a year earlier, as its healthcare division faced softer pharmacy 340B contract activity. The company recorded a net loss of $0.08 per share for the period. Despite the revenue drop, NextPlat shares moved 1.32% higher in pre-market…
-

Tharimmune Shares Jump After FDA Signals Support for TH104 Modeling Plan
Tharimmune, Inc. (NASDAQ:THAR) saw its stock climb 11% on Thursday after the company said U.S. regulators offered constructive feedback on the development pathway for TH104, its nalmefene buccal-film candidate designed to prevent respiratory depression caused by fentanyl and other high-potency opioids. The company reported that the FDA agreed with its proposed simulation modeling strategy for…